» Articles » PMID: 38798058

Parkinson's Disease is Associated with Low Striated Esophagus Contractility Potentially Contributing to the Development of Dysphagia

Overview
Date 2024 May 27
PMID 38798058
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Parkinson's disease (PD) is the second most common neurodegenerative disorder, and more than 80% of PD patients will develop oropharyngeal dysphagia. Despite its striated histology, proximity to airway, and potential negative impact of its dysfunction on bolus transport and airway safety, the contractile function of the striated esophagus in PD patients has not been systematically studied.

Methods: Using our repository of clinical manometry and the Milwaukee ManoBank, we analyzed high-resolution manometry (HRM) studies of 20 PD patients, mean age 69.1 (range 38-87 years); 30 non-PD patients with dysphagia, mean age 64.0 (44-86 years); and 32 healthy volunteers, mean age 65.3 (39-86 years). Patients with abnormal findings based on Chicago Classification 4.0 were identified. Repeat analysis was performed in 20% of the manometric tracings by a different investigator with inter-rater concordance between 0.91 and 0.99.

Key Results: The striated esophageal contractile integral in PD patients was significantly lower than that in non-PD dysphagic patients and healthy controls (p = 0.03 and <0.01, respectively). This significant difference persisted after excluding patients with concurrent Chicago Classification motility disorders (p = 0.02 and 0.01, respectively). In both analyses, the distal esophageal contractile integral did not show any significant difference between groups (p = 0.58 and 0.93, respectively).

Conclusions & Inferences: PD is associated with a significant decrease in striated esophagus contractility compared to non-PD and healthy controls. This finding may play a pathophysiologic role in development of dysphagia in this patient population.

References
1.
Jones C, Ciucci M . Multimodal Swallowing Evaluation with High-Resolution Manometry Reveals Subtle Swallowing Changes in Early and Mid-Stage Parkinson Disease. J Parkinsons Dis. 2016; 6(1):197-208. PMC: 4816667. DOI: 10.3233/JPD-150687. View

2.
Bodner R, Outeiro T, Altmann S, Maxwell M, Cho S, Hyman B . Pharmacological promotion of inclusion formation: a therapeutic approach for Huntington's and Parkinson's diseases. Proc Natl Acad Sci U S A. 2006; 103(11):4246-51. PMC: 1449678. DOI: 10.1073/pnas.0511256103. View

3.
Kurihara K, Kita K, Hirayama K, Hara T . [Dysphagia in Parkinson disease]. Rinsho Shinkeigaku. 1993; 33(2):150-4. View

4.
Vetrano D, Pisciotta M, Laudisio A, Lo Monaco M, Onder G, Brandi V . Sarcopenia in Parkinson Disease: Comparison of Different Criteria and Association With Disease Severity. J Am Med Dir Assoc. 2018; 19(6):523-527. DOI: 10.1016/j.jamda.2017.12.005. View

5.
Johnston B, Li Q, Castell J, Castell D . Swallowing and esophageal function in Parkinson's disease. Am J Gastroenterol. 1995; 90(10):1741-6. View